GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Span-America Medical Systems Inc (NAS:SPAN) » Definitions » Intrinsic Value: Projected FCF

Span-America Medical Systems (Span-America Medical Systems) Intrinsic Value: Projected FCF : $0.00 (As of May. 05, 2024)


View and export this data going back to 1983. Start your Free Trial

What is Span-America Medical Systems Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-05), Span-America Medical Systems's Intrinsic Value: Projected FCF is $0.00. The stock price of Span-America Medical Systems is $29.99. Therefore, Span-America Medical Systems's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Span-America Medical Systems's Intrinsic Value: Projected FCF or its related term are showing as below:

SPAN's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.7
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Span-America Medical Systems Intrinsic Value: Projected FCF Historical Data

The historical data trend for Span-America Medical Systems's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Span-America Medical Systems Intrinsic Value: Projected FCF Chart

Span-America Medical Systems Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.44 24.53 23.83 20.58 23.65

Span-America Medical Systems Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.80 23.70 23.65 24.12 23.70

Competitive Comparison of Span-America Medical Systems's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Span-America Medical Systems's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Span-America Medical Systems's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Span-America Medical Systems's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Span-America Medical Systems's Price-to-Projected-FCF falls into.



Span-America Medical Systems Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Span-America Medical Systems's Free Cash Flow(6 year avg) = $4.56.

Span-America Medical Systems's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar17)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*4.5592+28.672*0.8)/2.774
=23.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Span-America Medical Systems  (NAS:SPAN) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Span-America Medical Systems's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=29.99/23.915928982092
=1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Span-America Medical Systems Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Span-America Medical Systems's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Span-America Medical Systems (Span-America Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.
Executives
Terry Allison Rappuhn director P O BOX 58062, NASHVILLE TN 37205
Thomas Joseph Sullivan director 64 PETTIT PL PRINCETON NJ 08540
Robert B Johnston director

Span-America Medical Systems (Span-America Medical Systems) Headlines